Overexpression of BCL2, BCL6, VEGFR1 and TWIST1 in Circulating Tumor Cells Derived from Patients with DLBCL Decreases Event-Free Survival.
Onco Targets Ther
; 15: 1583-1595, 2022.
Article
in En
| MEDLINE
| ID: mdl-36606244
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Onco Targets Ther
Year:
2022
Document type:
Article
Country of publication:
New Zealand